文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症监护室中不早期肠外营养下的严格血糖控制

Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.
PubMed 文献 · N Engl J Med · 2023-01-01
一句话结论在未接受早期肠外营养的ICU患者中,严格血糖控制(80–110 mg/dL)与宽松血糖控制相比,未改变需要ICU监护的时间或90天死亡率。

该随机对照试验纳入9230例ICU患者,随机分为宽松血糖控制组(血糖>215 mg/dL时启动胰岛素)和严格血糖控制组(LOGIC-Insulin算法目标80–110 mg/dL),两组均停用肠外营养1周。主要终点为需要ICU监护的时间(以存活出院时间计算,死亡作为竞争风险),严格组与宽松组相似(HR 1.00; 95%CI 0.96–1.04; P=0.94)。90天死亡率两组相似(宽松组10.1% vs 严格组10.5%,P=0.51)。严格血糖控制未影响ICU监护时间或死亡率。

要点

  • 在未接受早期肠外营养的ICU患者中,严格血糖控制(目标80–110 mg/dL)与宽松血糖控制(血糖>215 mg/dL时启动胰岛素)相比,需要ICU监护的时间相似(HR 1.00; 95%CI 0.96–1.04; P=0.94)。
  • 90天死亡率在宽松组为10.1%,严格组为10.5%,两组相似(P=0.51)。
  • 严重低血糖发生率宽松组为0.7%(31例),严格组为1.0%(47例)。
  • 预设的8项次要结局分析提示,严格血糖控制组新发感染、呼吸和血流动力学支持持续时间、出院存活时间、ICU和住院死亡率与宽松组相似,而严重急性肾损伤和胆汁淤积性肝功能障碍似乎更少见。
  • 两组均停用肠外营养1周;中位晨间血糖宽松组为140 mg/dL(IQR 122–161),严格组为107 mg/dL(IQR 98–117)。

适用人群与场景

  • ICU入院患者,随机分组时纳入;两组均停用肠外营养1周。

诊断标准与关键阈值

  • 宽松血糖控制:仅当血糖>215 mg/dL(>11.9 mmol/L)时启动胰岛素。
  • 严格血糖控制:使用LOGIC-Insulin算法将血糖目标设定在80–110 mg/dL(4.4–6.1 mmol/L)。

处置流程与药物剂量

  • 宽松血糖控制组:仅在血糖>215 mg/dL(>11.9 mmol/L)时启动胰岛素。
  • 严格血糖控制组:使用LOGIC-Insulin算法调整胰岛素,目标血糖80–110 mg/dL(4.4–6.1 mmol/L)。
  • 两组均停用肠外营养1周。

红旗征与不能漏的情况

  • 严重低血糖:宽松组31例(0.7%),严格组47例(1.0%)。

研究设计与关键结果

  • 研究类型:随机对照试验;样本量9230例,随机分为宽松血糖控制组4622例和严格血糖控制组4608例。
  • 中位晨间血糖:宽松组140 mg/dL(IQR 122–161),严格组107 mg/dL(IQR 98–117)。
  • 主要终点(需要ICU监护的时间,以存活出院时间计算,死亡作为竞争风险):严格组与宽松组相似(HR for earlier discharge alive with tight glucose control 1.00; 95%CI 0.96–1.04; P=0.94)。
  • 90天死亡率:宽松组10.1%,严格组10.5%(P=0.51)。
  • 严重低血糖:宽松组31例(0.7%),严格组47例(1.0%)。
  • 预设的8项次要结局分析提示:新发感染、呼吸和血流动力学支持持续时间、出院存活时间、ICU和住院死亡率两组相似;严重急性肾损伤和胆汁淤积性肝功能障碍在严格血糖控制组似乎更少见。

证据类型、等级与局限

  • 证据类型:随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在未接受早期肠外营养的ICU患者中,严格血糖控制(目标80–110 mg/dL)未改变需要ICU监护的时间或死亡率,作者结论不支持该策略改善这些结局。
  • 严格血糖控制组严重低血糖发生率为1.0%,宽松组为0.7%。
  • 严重急性肾损伤和胆汁淤积性肝功能障碍在严格血糖控制组似乎更少见(基于预设次要结局分析)。

指南或共识出处

  • TGC-Fast试验(ClinicalTrials.gov number, NCT03665207)

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Randomized, controlled trials have shown both benefit and harm from tight blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early parenteral nutrition and in insulin-induced severe hypoglycemia might explain this inconsistency.

METHODS: We randomly assigned patients, on ICU admission, to liberal glucose control (insulin initiated only when the blood-glucose level was >215 mg per deciliter [>11.9 mmol per liter]) or to tight glucose control (blood-glucose level targeted with the use of the LOGIC-Insulin algorithm at 80 to 110 mg per deciliter [4.4 to 6.1 mmol per liter]); parenteral nutrition was withheld in both groups for 1 week. Protocol adherence was determined according to glucose metrics. The primary outcome was the length of time that ICU care was needed, calculated on the basis of time to discharge alive from the ICU, with death accounted for as a competing risk; 90-day mortality was the safety outcome.

RESULTS: Of 9230 patients who underwent randomization, 4622 were assigned to liberal glucose control and 4608 to tight glucose control. The median morning blood-glucose level was 140 mg per deciliter (interquartile range, 122 to 161) with liberal glucose control and 107 mg per deciliter (interquartile range, 98 to 117) with tight glucose control. Severe hypoglycemia occurred in 31 patients (0.7%) in the liberal-control group and 47 patients (1.0%) in the tight-control group. The length of time that ICU care was needed was similar in the two groups (hazard ratio for earlier discharge alive with tight glucose control, 1.00; 95% confidence interval, 0.96 to 1.04; P = 0.94). Mortality at 90 days was also similar (10.1% with liberal glucose control and 10.5% with tight glucose control, P = 0.51). Analyses of eight prespecified secondary outcomes suggested that the incidence of new infections, the duration of respiratory and hemodynamic support, the time to discharge alive from the hospital, and mortality in the ICU and hospital were similar in the two groups, whereas severe acute kidney injury and cholestatic liver dysfunction appeared less prevalent with tight glucose control.

CONCLUSIONS: In critically ill patients who were not receiving early parenteral nutrition, tight glucose control did not affect the length of time that ICU care was needed or mortality. (Funded by the Research Foundation-Flanders and others; TGC-Fast ClinicalTrials.gov number, NCT03665207.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Gunst J, Debaveye Y, Güiza F, et al. Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU. N Engl J Med. 2023. PMID: 37754283. doi:10.1056/NEJMoa2304855

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。